Market Overview:
The global obeticholic acid drug market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic liver diseases, rising awareness about obeticholic acid drugs, and increasing R&D investments by pharmaceutical companies. The global obeticholic acid drug market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into 5mg and 10mg tablets. On the basis of application, the market is segmented into primary biliary cirrhosis (PBC), nonalcoholic fatty liver disease (NAFLD), and other applications. The PBC segment accounts for a major share of this market owing to high prevalence rates for PBC across regions. Geographically, this market is divided into North America, Latin America, Europe Asia Pacific ,and Middle East & Africa .
Product Definition:
Obeticholic acid is a drug used to treat primary biliary cirrhosis, a liver disease. It works by preventing the body from making cholesterol, which can build up in the liver and damage it. Obeticholic acid is important because it can help improve liver function in people with this disease.
5mg:
Obeticholic acid is a type of fatty acid that is naturally produced by the body and can be extracted from plant oils like soybean, sunflower, rapeseed oil, and others. The extraction process for obeticholic acid requires chemical or enzymatic hydrolysis which helps in breaking down the bonds between carbon & hydrogen in the chain length of polyunsaturated fatty acids.
10mg:
Obeticholic acid is a form of fatty acid that is naturally produced by the body and can be extracted from plant oils like soybean, sunflower, rapeseed, and corn oil. It has been found to have beneficial effects in the treatment of cancer as well as cardiovascular diseases.
Application Insights:
Nonalcoholic fatty liver disease (NAFLD) held the largest share of over 25.0% in 2017. The growing prevalence of obesity and unhealthy lifestyle habits has led to the development of this condition in patients, which is anticipated to fuel demand for OBPA drugs over the forecast period. As per U.S., around 90% of patients with nonalcoholic steatosis have been found to be asymptomatic carriers of HBV, thus fueling demand for obeticholic acid drugs in NAFLD treatment globally.
Primary biliary cirrhosis (PBC) is expected to grow at a significant rate during the forecast period due largely on factors such as increasing cases worldwide chronic hepatitis B & C infections.
Regional Analysis:
North America was the largest regional market in 2017 owing to high awareness levels and availability of a large patient pool. The region is expected to maintain its dominance over the forecast period due to increasing R&D initiatives, rising healthcare spending, and growing adoption of new technologies. In addition, presence of key manufacturers in this region will also help Obeticholic Acid drug retain its position as a leader in the global arena.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast period owing to improving economic conditions and growing medical tourism industry especially in China & India & Japan etcetera.
Growth Factors:
- Increasing prevalence of liver diseases and disorders
- Growing demand for novel and effective treatment options for liver diseases
- Rising awareness about the benefits of Obeticholic Acid Drug therapy
- increasing number of clinical studies supporting the use of Obeticholic Acid Drug in the treatment of various liver diseases
- growing investment in research and development activities for new Obeticholic Acid Drug therapies
Scope Of The Report
Report Attributes
Report Details
Report Title
Obeticholic Acid Drug Market Research Report
By Type
5mg, 10mg
By Application
Primary Biliary Cirrhosis, Nonalcoholic Fatty Liver Disease, Other
By Companies
Intercept Pharmaceuticals, Dainippon Sumitomo Pharma
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
247
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Obeticholic Acid Drug Market Report Segments:
The global Obeticholic Acid Drug market is segmented on the basis of:
Types
5mg, 10mg
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Primary Biliary Cirrhosis, Nonalcoholic Fatty Liver Disease, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Intercept Pharmaceuticals
- Dainippon Sumitomo Pharma
Highlights of The Obeticholic Acid Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 5mg
- 10mg
- By Application:
- Primary Biliary Cirrhosis
- Nonalcoholic Fatty Liver Disease
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Obeticholic Acid Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Obeticholic acid is a drug that is used to treat heart failure. It works by improving the function of the heart muscle.
Some of the major companies in the obeticholic acid drug market are Intercept Pharmaceuticals, Dainippon Sumitomo Pharma.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Obeticholic Acid Drug Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Obeticholic Acid Drug Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Obeticholic Acid Drug Market - Supply Chain
4.5. Global Obeticholic Acid Drug Market Forecast
4.5.1. Obeticholic Acid Drug Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Obeticholic Acid Drug Market Size (000 Units) and Y-o-Y Growth
4.5.3. Obeticholic Acid Drug Market Absolute $ Opportunity
5. Global Obeticholic Acid Drug Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Obeticholic Acid Drug Market Size and Volume Forecast by Type
5.3.1. 5mg
5.3.2. 10mg
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Obeticholic Acid Drug Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Obeticholic Acid Drug Market Size and Volume Forecast by Application
6.3.1. Primary Biliary Cirrhosis
6.3.2. Nonalcoholic Fatty Liver Disease
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Obeticholic Acid Drug Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Obeticholic Acid Drug Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Obeticholic Acid Drug Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Obeticholic Acid Drug Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Obeticholic Acid Drug Demand Share Forecast, 2019-2026
9. North America Obeticholic Acid Drug Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Obeticholic Acid Drug Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Obeticholic Acid Drug Market Size and Volume Forecast by Application
9.4.1. Primary Biliary Cirrhosis
9.4.2. Nonalcoholic Fatty Liver Disease
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Obeticholic Acid Drug Market Size and Volume Forecast by Type
9.7.1. 5mg
9.7.2. 10mg
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Obeticholic Acid Drug Demand Share Forecast, 2019-2026
10. Latin America Obeticholic Acid Drug Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Obeticholic Acid Drug Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Obeticholic Acid Drug Market Size and Volume Forecast by Application
10.4.1. Primary Biliary Cirrhosis
10.4.2. Nonalcoholic Fatty Liver Disease
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Obeticholic Acid Drug Market Size and Volume Forecast by Type
10.7.1. 5mg
10.7.2. 10mg
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Obeticholic Acid Drug Demand Share Forecast, 2019-2026
11. Europe Obeticholic Acid Drug Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Obeticholic Acid Drug Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Obeticholic Acid Drug Market Size and Volume Forecast by Application
11.4.1. Primary Biliary Cirrhosis
11.4.2. Nonalcoholic Fatty Liver Disease
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Obeticholic Acid Drug Market Size and Volume Forecast by Type
11.7.1. 5mg
11.7.2. 10mg
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Obeticholic Acid Drug Demand Share, 2019-2026
12. Asia Pacific Obeticholic Acid Drug Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Obeticholic Acid Drug Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Obeticholic Acid Drug Market Size and Volume Forecast by Application
12.4.1. Primary Biliary Cirrhosis
12.4.2. Nonalcoholic Fatty Liver Disease
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Obeticholic Acid Drug Market Size and Volume Forecast by Type
12.7.1. 5mg
12.7.2. 10mg
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Obeticholic Acid Drug Demand Share, 2019-2026
13. Middle East & Africa Obeticholic Acid Drug Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Obeticholic Acid Drug Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Obeticholic Acid Drug Market Size and Volume Forecast by Application
13.4.1. Primary Biliary Cirrhosis
13.4.2. Nonalcoholic Fatty Liver Disease
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Obeticholic Acid Drug Market Size and Volume Forecast by Type
13.7.1. 5mg
13.7.2. 10mg
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Obeticholic Acid Drug Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Obeticholic Acid Drug Market: Market Share Analysis
14.2. Obeticholic Acid Drug Distributors and Customers
14.3. Obeticholic Acid Drug Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Intercept Pharmaceuticals
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Dainippon Sumitomo Pharma
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. COMPANY3
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. COMPANY4
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. COMPANY5
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
